Form Bio
Form Bio provides a variety of features, including workflows, data management, collaboration, data visualisation, and workflow catalogue. It provides solutions for lab directors, biotech, pharma, academics, and other fields.
Form Bio
Form Bio provides a variety of features, including workflows, data management, collaboration, data visualisation, and workflow catalogue. It provides solutions for lab directors, biotech, pharma, academics, and other fields.
TL;DR
Founded: 2022 (spinout from Colossal Biosciences)
Core offering: AI-driven platform for genetic-medicine, genome engineering, and bioinformatics
Notable tech/products: Proprietary AI models (branded FORMsight), workflows, data management, visualization
Reported funding: $30M Series A (announced Sept 27, 2022)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Computational biology, bioinformatics, and AI-accelerated therapeutic development for genome engineering and genetic medicines.
Founded
2022
Industry
Software Development
Tech Stack
Funding Track Record
$30,000,000
Announced at company spinout; other named investors include Thomas Tull and additional strategic/backer investors.
Investor Signal
“Led by venture investor Jazz Venture Partners with participation from individual/strategic backers (e.g., Thomas Tull)”